Search by Drug Name or NDC
NDC 00409-1162-01 BUPIVACAINE HYDROCHLORIDE 5 mg/mL Details
BUPIVACAINE HYDROCHLORIDE 5 mg/mL
BUPIVACAINE HYDROCHLORIDE is a EPIDURAL; INTRACAUDAL; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is BUPIVACAINE HYDROCHLORIDE.
Product Information
| NDC | 00409-1162 |
|---|---|
| Product ID | 0409-1162_a33878a1-9d68-4a46-9913-c7be85f1d1ff |
| Associated GPIs | 69100010102012 |
| GCN Sequence Number | 052194 |
| GCN Sequence Number Description | bupivacaine HCl/PF VIAL 5 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 19758 |
| HICL Sequence Number | 025243 |
| HICL Sequence Number Description | BUPIVACAINE HCL/PF |
| Brand/Generic | Generic |
| Proprietary Name | BUPIVACAINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | bupivacaine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | EPIDURAL; INTRACAUDAL; PERINEURAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | BUPIVACAINE HYDROCHLORIDE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA070584 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-1162-01 (00409116201)
| NDC Package Code | 0409-1162-01 |
|---|---|
| Billing NDC | 00409116201 |
| Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-1162-01) / 10 mL in 1 VIAL, SINGLE-DOSE (0409-1162-18) |
| Marketing Start Date | 2006-03-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |